Takeda Pharmaceutical Company Limited
Prognozy (mln)
| Okres |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
2028-03-31 |
2029-03-31 |
2030-03-31 |
2031-03-31 |
| Przychód (średnia) |
3,980,761.19 |
4,113,962.36 |
4,695,249.20 |
4,822,278.26 |
4,871,349.01 |
4,947,908.33 |
5,117,767.80 |
5,239,946.92 |
| Przychód Δ r/r |
0.00% |
3.35% |
14.13% |
2.71% |
1.02% |
1.57% |
3.43% |
2.39% |
| Przychód (min) |
3,875,937.79 |
4,070,041.05 |
4,692,029.97 |
4,771,535.24 |
4,650,989.71 |
4,732,743.60 |
4,895,216.56 |
5,012,082.60 |
| Przychód (max) |
4,127,044.61 |
4,157,883.66 |
4,698,468.44 |
4,871,329.85 |
5,052,237.40 |
5,122,352.39 |
5,298,200.45 |
5,424,687.13 |
| EBITDA (średnia) |
1,119,278.37 |
1,156,730.80 |
1,320,172.35 |
1,355,889.36 |
1,369,686.68 |
1,391,213.01 |
1,438,972.73 |
1,473,326.07 |
| EBIT (średnia) |
441,390.32 |
456,159.78 |
520,613.38 |
534,698.47 |
540,139.48 |
548,628.44 |
567,462.61 |
581,009.94 |
| EBIT % |
11.09% |
11.09% |
11.09% |
11.09% |
11.09% |
11.09% |
11.09% |
11.09% |
| Zysk netto (średni) |
158,398.44 |
141,021.34 |
137,648.57 |
260,121.01 |
324,851.96 |
368,983.67 |
376,380.78 |
422,304.12 |
| Zysk netto % |
3.98% |
3.43% |
2.93% |
5.39% |
6.67% |
7.46% |
7.35% |
8.06% |
| EPS (średnia) |
100.23 |
44.62 |
43.55 |
82.30 |
102.78 |
116.74 |
119.08 |
133.61 |
| Liczba analityków (Przychody) |
1 |
2 |
9 |
9 |
16 |
11 |
11 |
10 |
| Liczba analityków (EPS) |
1 |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
| symbol |
TAK |
TAK |
TAK |
TAK |
TAK |
TAK |
TAK |
TAK |